CBD Market Continues to Be a Leader

HENDERSON, NV / ACCESSWIRE / March 19, 2019 / Brightfield estimates the size of the market for hemp-derived CBD products to be about $591 million in 2018. It further estimates that the market will hit $22 billion by 2022, potentially growing almost 40 times in next 4 years. Hemp Business Journal says the market for hemp-derived CBD was about $190 million in 2017 and will grow to $646 million by 2022.

One potential leader in this growing market segment is Real Brands, Inc. (RLBD). RLBD has strong management with a solid background in branding and the beverage industry and plans to expand their holdings focusing on at least three CBD Categories: smokables, edibles and topical balms and lotions. The company recently updated their logo and brand identity. It is also developing an E-Commerce website and plans to launch it during the early part of the second quarter on their newly acquired domain name to support online sales of a variety of smokable, edible, and topical CBD derived from Hemp based products for each of their brands. Start your research today.

Today we are highlighting: Real Brands, Inc. (RLBD), Tilray, Inc. (TLRY), TerraTech Corp. (TRTC), HEXO Corp. (NYSE AMERICAN: HEXO), and Emerald Health Therapeutics, Inc. (EMHTF).

Real Brands, Inc. (RLBD) (Market Cap: $12.577M; Share Price: $0.095) is launching a CBD beverage called Omegahempâ„¢ Water. The company is very close to its next production run, meaning there could be major news on the way. The audit on the horizon means this could also be another major event for investors to pay attention to. Real Brands is first and foremost a marketing and branding company, which has been slowly building its portfolio of trademarked brand names that could each represent on their own major partnerships and joint ventures going forward.

Current product and brand names under Real Brands:

- Humboldt Brands®
- Hemp-Aid®
- HempAid®
- CBD Pharmacyâ„¢
- Omegahempâ„¢

Jerry Pearring, the CEO of Real Brands commented, "As the demand for CBD infused products continues to grow, we intend to create marketing strategies in at least three CBD Categories: smokables, edibles and topical balms and lotions."

Tilray, Inc. (TLRY) (Market Cap: $6.923B; Share Price: $72.24) is buying Manitoba Harvest, the world's largest hemp foods manufacturer, for $316 million from Compass Diversified Holdings, eyeing the growing CBD food and drink market in the U.S.. The deal will help Tilray tap into extensive US distribution network and upcoming line of CBD products of Manitoba Harvest.

Terra Tech Corp. (TRTC) (Market Cap: $92.183M; Share Price: $0.992) announced the company has agreed to acquire the remaining stake in the Blüm Reno dispensary in Nevada. Under the agreement, Terra Tech will increase its stake in the Reno, Nev.-based dispensary to 100% from 50%. The acquisition includes the Blüm dispensary's cannabis licenses as well. Additionally, Terra Tech's ownership in the building which houses the dispensary will increase from 50% to 100%. The agreement is subject to the approval of the Nevada Department of Taxation. The company expects to receive response within 60 to 90 days.

HEXO Corp. (HEXO) (Market Cap: $1.407B; Share Price: $6.73) had announced in August 2018 that it is forming a joint venture with Molson Coors. The company is partnering with HEXO, which'll likely be a top-10 producer by peak annual output. Molson Coors gets its foot in the door in a fast-growing industry, while giving HEXO the marketing leadership it needs.

Emerald Health Therapeutics, Inc. (EMHTF) (Market Cap: $436.883M; Share Price: $3.083) announced the launch of Verdélite Sciences Inc., a wholly-owned, Québec-based production subsidiary licensed by Health Canada. Formerly known as Agro-Biotech, Verdélite currently produces high-grade dried cannabis for medical and adult-use purposes.

Signed by

Priyanka Goel, CFA

Legal Disclaimer:

This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three-month term consulting agreement with RLBD dated 8/31/18. The agreement calls for $100,000 note issued to Regal Consulting, and 2,500,000 restricted 144 shares of RLBD for three months of service. Regal has elected to convert $73,000 of principal of the $100,000 note into 2,761,872 Restricted 144 shares of RLBD. Regal Consulting has agreed to a twelve- month term consulting agreement with RLBD dated 1/4/2019. The agreement calls for $10,000 in cash and 500,000 shares per month. All payments were made directly by Real Brands, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. RLBD was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.